STOCKHOLDERS EQUITY

6 Months Ended

Jun. 30, 2021

STOCKHOLDERS EQUITY

NOTE - 3 STOCKHOLDERS' EQUITY

NOTE 3 – STOCKHOLDERS’ EQUITY

Authorized shares

As of June 30, 2021 and December 31, 2020, the Company’s authorized shares were 5,000,000 shares of preferred stock, with a par value of $0.001.

As of June 30, 2021 and December 31, 2020, the Company’s authorized shares were 2,000,000,000 shares of common stock, with a par value of $0.001.

Issued and outstanding shares

Common stock

In January 2021, the Company completed the issuance of 900,000 shares of its common stock to six individuals of consultants and service providers for their services rendered to the Company.

Series B Preferred Stock

On April 12, 2021, the Company designated a class of preferred stock titled, Series B Preferred Stock, with a par value of $0.001 per share, and consisting of one share. The Series B preferred carries voting rights equal to 110% of the total voting rights of the outstanding common stock and voting power of the Company, and has the right to appoint one director of the Company.

As of June 30, 2021 and December 31, 2020, the Company had 1,000,000 shares of Series A preferred stock issued and outstanding.

As of June 30, 2021 and December 31, 2020, the Company had 1 and 0 share of Series B preferred stock issued and outstanding, respectively.

As of June 30, 2021 and December 31, 2020, the Company had 8,099,119 and 10,199,119 shares of common stock issued and outstanding, respectively.